Four new hemiterpenoid derivatives from Taxillus chinensis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Four new hemiterpenoid derivatives from Taxillus chinensis

Published:2013-04 Issue: Volume:86 Page:1-5
ISSN:0367-326X
Container-title:Fitoterapia
language:en
Short-container-title:Fitoterapia

Author:

Ding Bo,Dai Yi,Hou Yun-Long,Wu Xiao-Meng,Chen Xue,Yao Xin-Sheng

Funder

Ministry of Science and Technology of China

Key Drug Discovery Project of 12th Five-year plan

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,General Medicine

Reference24 articles.

1. The value of natural products to future pharmaceutical discovery;Baker;Nat Prod Rep,2007

2. Natural products as sources of new drugs over the 30years from 1981–2010;Newman;J Nat Prod,2012

3. Natural products in drug discovery and development;Cragg;J Nat Prod,1997

4. Chinese pharmacopoeia, part 1;Chinese Pharmacopoeia Commission,2010

5. Parasitic loranthus from Loranthaceae rather than Viscaceae potently inhibits fatty acid synthase and reduces body weight in mice;Wang;J Ethnopharmacol,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Taxillus chinensis (DC.) Danser: a comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and toxicology;Chinese Medicine;2022-12-08

2. Screening and identification of anti-acetylcholinesterase ingredients from Tianzhi granule based on ultrafiltration combined with ultra-performance liquid chromatography-mass spectrometry and in silico analysis;Journal of Ethnopharmacology;2022-11

3. Comparative Proteomic Analysis Provides New Insights into the Development of Haustorium in Taxillus chinensis (DC.) Danser;BioMed Research International;2022-07-28

4. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications;Phytomedicine;2022-04

5. Treatment and bioresources utilization of traditional Chinese medicinal herb residues: Recent technological advances and industrial prospect;Journal of Environmental Management;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3